Alyeska Investment Group
EVLO

Alyeska Investment Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Alyeska Investment Group’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-265,103
Closed -$1.04M – 699
2023
Q3 		$1.04M Buy
+265,103
New +$1.81M 0.01% 420

Other funds holding EVLO

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Alyeska Investment Group's EVLO Position: Q4 2023 in Review

Alyeska Investment Group sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2023, closing a stake of 265,103 shares — an estimated $1.04M sold.

Alyeska Investment Group first reported a position in EVLO in Q3 2023 and held it in 1 quarter. The position peaked at $1.04M in Q3 2023. 2 funds tracked by Wall St. Rank hold EVLO as of Q4 2023.

  • Alyeska Investment Group reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 265,103 Evelo Biosciences, Inc. Common Stock shares in Q4 2023, an estimated $1.04M.
  • Alyeska Investment Group first reported a position in Evelo Biosciences, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Alyeska Investment Group's Evelo Biosciences, Inc. Common Stock position peaked at $1.04M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.